BACTERIAL LYSATES AND RIBOSOMES AS INDUCERS OF SPECIFIC IMMUNE-RESPONSES - A COMPARATIVE-STUDY

被引:16
作者
BENE, MC
KAHL, L
PERRUCHET, AM
HERMES, H
MOSGES, M
NORMIER, G
BINZ, H
FAURE, GC
机构
[1] CTR IMMUNOL & BIOL PIERRE FABRE,ST JULIEN GENEVOI,FRANCE
[2] MED FAK AACHEN,HALS NASEN OHRENICRANICHEITEN & PLAST KOPF & HALSCHIRURG ABT,AACHEN,GERMANY
关键词
D O I
10.1111/j.1365-3083.1993.tb02594.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A bacterial lysate (OM-85 BV), a preparation of purified bacterial ribosomes (D53) and a placebo were tested for ability to induce the local appearance of specific antibody-containing cells. The three compounds were given orally to 90 children who required tonsillectomy. Surgery was carried out after 1 month of therapy. Frozen-cut sections of each tonsil were tested in indirect immunofluorescence. Cells containing antibodies directed to Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae or Klebsiella pneumoniae were enumerated. Lowest values were noted in the placebo group. Slightly higher numbers were observed after treatment with OM-85 BV, but significant increases were noted only for the elevated numbers of specific antibody-containing cells observed after D53 therapy. Bacterial ribosomal preparations thus contribute efficient induction of specific local immune responses in man.
引用
收藏
页码:496 / 498
页数:3
相关论文
共 10 条
[1]   VACCINES FOR THE THIRD-WORLD [J].
BLOOM, BR .
NATURE, 1989, 342 (6246) :115-120
[2]   INCREASE IN SPECIFIC ANTIBODY-FORMING-CELLS IN HUMAN TONSILS AFTER ORAL-STIMULATION WITH D-53, A RIBOSOMAL VACCINE [J].
FAURE, GC ;
BENE, MC ;
SIMON, C ;
QUANTAIN, A .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1990, 12 (03) :315-320
[3]   MUCOSAL IMMUNITY - IMPLICATIONS FOR VACCINE DEVELOPMENT [J].
HOLMGREN, J ;
CZERKINSKY, C ;
LYCKE, N ;
SVENNERHOLM, AM .
IMMUNOBIOLOGY, 1992, 184 (2-3) :157-179
[4]   THE MUCOSAL IMMUNE-SYSTEM - FROM FUNDAMENTAL-CONCEPTS TO VACCINE DEVELOPMENT [J].
MCGHEE, JR ;
MESTECKY, J ;
DERTZBAUGH, MT ;
ELDRIDGE, JH ;
HIRASAWA, M ;
KIYONO, H .
VACCINE, 1992, 10 (02) :75-88
[5]  
Menardo J L, 1982, Poumon Coeur, V38, P297
[6]   IMMUNO-STIMULATION BY A RIBOSOMAL VACCINE ASSOCIATED WITH A BACTERIAL-CELL WALL ADJUVANT IN HUMANS [J].
MICHEL, FB ;
DHINTERLAND, LD ;
BOUSQUET, J ;
PINEL, AM ;
NORMIER, G .
INFECTION AND IMMUNITY, 1978, 20 (03) :760-769
[7]  
OGRA PL, 1984, REV INFECT DIS, V6, pS361
[8]   ORAL DELIVERY OF VACCINES - FORMULATION AND CLINICAL PHARMACOKINETIC CONSIDERATIONS [J].
OHAGAN, DT .
CLINICAL PHARMACOKINETICS, 1992, 22 (01) :1-10
[9]  
PHILLIPSQUAGLIA.JM, 1988, MIGRATION HOMING LYM, V2, P53
[10]  
ZANIN C, 1992, PATHOL BIOL, V40, P599